A recent study suggests that patients who come off new weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who stop traditional lifestyle programs.
Research printed in a leading medical journal shows that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"People buying such medications must be informed of the risk of fast weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.
That rate of regain suggests a return to original weight in about 18 months.
Analyzing Therapies
The analysis, which examined dozens of studies involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with other pills.
The team emphasize that individuals who lose weight through diet and exercise typically have a more gradual creep back—around 100 grams monthly—after stopping.
Understanding the Fast Rebound
Doctors suggest the way of the jabs accounts for the heightened rebound.
These medications imitate a body's own chemical called GLP-1, which controls appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the system to produce less of its endogenous GLP-1, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Condition?
Health authorities advise the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, due to the significant potential of weight regain, the treatment might need to be ongoing.
This perspective is supported by drug manufacturers, who note that the results "emphasize the persistent nature of excess weight," similar to managing diseases like high blood pressure.
User Accounts
Individuals who have stopped the medication report a intense return of appetite.
"It was like a switch flipping and you're instantly extremely hungry," recalled an individual.
This difficulty is compounded if patients have not adopted lasting lifestyle or habit changes during treatment.
Significant Interest
Recent estimates indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is greater among females compared to males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while the jabs are potent tools for shedding pounds, they are not a standalone cure and long-term success hinges on integrated lifestyle management.
